Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB5857 relative and absolute bioavailability study in healthy volunteers
NL-OMON41752Active, not recruiting
- Sponsor
- UCB
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of seletalisib in rheumatoid arthritis (RA) and Sjögren's syndrome, sponsored by UCB. Started Mar 2015; status: active, not recruiting.
02
Drugs
seletalisib
03
Conditions
rheumatoid arthritis (RA)Sjögren's syndrome
Beyond the preview
Go deeper on NL-OMON41752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41752.